Binding of the doxorubicin-lactosaminated human albumin conjugate to HCC cells is mediated by the drug moieties.
Baglioni
M
M
Fiume
L
L
Bolondi
L
L
Farina
C
C
Kratz
F
F
Di Stefano
G
G
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000493:pharmacokinetics*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D045744:Cell Line, Tumor; D004317:Doxorubicin / Q000493:pharmacokinetics*; D004337:Drug Carriers / Q000493:pharmacokinetics; D015195:Drug Design; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D051381:Rats; D012709:Serum Albumin / Q000493:pharmacokinetics
D000903:Antibiotics, Antineoplastic; D004337:Drug Carriers; D012709:Serum Albumin; C046912:lactosaminated serum albumin; D004317:Doxorubicin